Priming of the antitumor response promotes efficacy of interleukin-2therapy

L.A. Everse, M.R. Bernsen, H.F.J. Dullens, W. den Otter

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)221-229
Number of pages9
JournalCancer Immunology, Immunotherapy
Volume44
Publication statusPublished - 1997

Keywords

  • Econometric and Statistical Methods: General
  • Medical technology
  • Farmacie(FARM)
  • Geneeskunde(GENK)
  • Bescherming en bevordering van de menselijke gezondheid
  • Biomedische technologie en medicijnen
  • Immunology
  • Pharmacology

Cite this